Avanir Pharmaceuticals Inc-Strategic SWOT Analysis Review

Avanir Pharmaceuticals Inc-Strategic SWOT Analysis Review


  • Products Id :- GDPH59410SA
  • |
  • Pages: 23
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Avanir Pharmaceuticals Inc-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-GlobalData's summarization of the company's business strategy.

SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

Avanir Pharmaceuticals Inc (Avanir) a subsidiary of Otsuka America, Inc. is a biopharmaceutical company which focuses on developing medicines for patients suffering from central nervous system disorders. The company's lead products include NUEDEXTA (AVP-923), a first-in-class dual N-methyl-D-aspartate (NMDA) rector antagonist and sigma-1 agonist is approved in the US and Europe for the treatment of pseudobulbar affect (PBA); and ONZETRA Xsail is for the treatment of migraine with or without aura in adult is approved in the US. Its AVP-786 has been developed for the treatment of depression and schizophrenia. The company is also developing various products under pipeline for the treatment of CNS disorders. Avanir is headquartered in Aliso Viejo, California, the US.

Avanir Pharmaceuticals Inc Key Recent Developments

Nov 29,2016: Avanir Pharmaceuticals Appoints Richard Malamut, MD, as Senior Vice President, Research & Development, and Chief Medical Officer

Jan 25,2016: Avanir Pharmaceuticals appoints new president and CEO

Jan 20,2016: Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as President and Chief Executive Officer

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Avanir Pharmaceuticals Inc-Key Facts 5

Avanir Pharmaceuticals Inc-Key Employees 6

Avanir Pharmaceuticals Inc-Key Employee Biographies 7

Avanir Pharmaceuticals Inc-Major Products and Services 8

Avanir Pharmaceuticals Inc-History 9

Avanir Pharmaceuticals Inc-Locations And Subsidiaries 10

Head Office 10

Other Locations & Subsidiaries 10

Section 2-Company Analysis 11

Avanir Pharmaceuticals Inc-Business Description 11

Avanir Pharmaceuticals Inc-Corporate Strategy 12

Avanir Pharmaceuticals Inc-SWOT Analysis 13

SWOT Analysis-Overview 13

Avanir Pharmaceuticals Inc-Strengths 13

Avanir Pharmaceuticals Inc-Weaknesses 14

Avanir Pharmaceuticals Inc-Opportunities 15

Avanir Pharmaceuticals Inc-Threats 16

Avanir Pharmaceuticals Inc-Key Competitors 17

Section 3-Company's Lifesciences Financial Deals and Alliances 18

Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 18

Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 19

Avanir Pharmaceuticals Inc, Recent Deals Summary 20

Section 4-Company's Recent Developments 21

Nov 29, 2016: Avanir Pharmaceuticals Appoints Richard Malamut, MD, as Senior Vice President, Research & Development, and Chief Medical Officer 21

Jan 20, 2016: Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as President and Chief Executive Officer 22

Section 5-Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23

List of Figures

Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 18

Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 19

List of Tables

Avanir Pharmaceuticals Inc, Key Facts 5

Avanir Pharmaceuticals Inc, Key Employees 6

Avanir Pharmaceuticals Inc, Key Employee Biographies 7

Avanir Pharmaceuticals Inc, Major Products and Services 8

Avanir Pharmaceuticals Inc, History 9

Avanir Pharmaceuticals Inc, Subsidiaries 10

Avanir Pharmaceuticals Inc, Key Competitors 17

Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 18

Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 19

Avanir Pharmaceuticals Inc, Recent Deals Summary 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Avanir Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

select a license

Single User License
USD 125 INR 8324
Site License
USD 250 INR 16648
Corporate User License
USD 375 INR 24971

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com